Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma
R. Ordonez, M. Kulis, N. Russinol, V. Chapaprieta, R. Beekman, C. Meydan, M. Duran-Ferrer, N. Verdaguer-Dot, G. Clot, R. Vilarrasa-Blasi, L. Garate, E. Miranda, A. Carrasco, T. Ezponda, A. Vilas-Zornoza, , J. I. Martin-Subero
The paper identifies aberrant chromatin activation as a common mechanism driving the malignant phenotype in multiple myeloma.
bioRxiv · Aug 20, 2019Cancer Biology